Suppr超能文献

在具有1型人类免疫缺陷病毒中和活性的血清反应阴性个体中发现的抗细胞抗体。

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.

作者信息

Lopalco L, Pastori C, Cosma A, Burastero S E, Capiluppi B, Boeri E, Beretta A, Lazzarin A, Siccardi A G

机构信息

DIBIT and Infectious Diseases Clinic, San Raffaele Scientific Institute, Milan, Italy.

出版信息

AIDS Res Hum Retroviruses. 2000 Jan 20;16(2):109-15. doi: 10.1089/088922200309458.

Abstract

Despite repeated exposures to HIV-1, some individuals remain seronegative. This study reports that sera from a fraction of exposed seronegative (ESN) subjects showed HIV-neutralizing activity; 5 of 17 ESN sera and none of 17 controls neutralized two different HIV-1 primary isolates (range of neutralizing titers: 1/20 to 1/60). The neutralizing activity was associated with the IgG fraction of 4 of 4 neutralizing ESN sera. Moreover, in 11 of 17 and 9 of 17 ESN sera (but none of the control sera) we found antibodies against HLA class I and CD4, respectively. One of the ESN sera (EU22) neutralized efficiently the primary virus derived from the seropositive partner and showed a good broadly cross-reactive neutralization. Immunoadsorption of two IgG fractions from EU19 and EU22 on peripheral blood mononuclear cells (PBMC) removed virus-neutralizing antibodies. The correlations between the ESN status and neutralizing activity (p<0.05), anti-HLA antibodies (p<0.0002), and anti-CD4 antibodies (p<0.001) were statistically significant. However, there was no statistically significant correlation between neutralizing activity and either anti-HLA or anti-CD4 antibodies. It can therefore be said that exposure to HIV-1 without seroconversion is, in some individuals, associated with HIV-neutralizing antibodies (not directed against viral antigens) and/or with anti-cell autoantibodies, which are possibly specific for cellular antigens involved in the infection/entry process.

摘要

尽管多次接触HIV-1,但一些个体仍保持血清学阴性。本研究报告称,一部分暴露后血清学阴性(ESN)受试者的血清显示出HIV中和活性;17份ESN血清中的5份以及17份对照血清中均无中和两种不同HIV-1原始毒株的能力(中和效价范围:1/20至1/60)。中和活性与4份具有中和作用的ESN血清中的IgG组分相关。此外,在17份ESN血清中的11份以及17份ESN血清中的9份(但对照血清中均无)中,我们分别发现了针对HLA I类分子和CD4的抗体。其中一份ESN血清(EU22)能有效中和来自血清学阳性伴侣的原始病毒,并表现出良好的广泛交叉反应中和能力。用EU19和EU22的两个IgG组分对外周血单核细胞(PBMC)进行免疫吸附可去除病毒中和抗体。ESN状态与中和活性(p<0.05)、抗HLA抗体(p<0.0002)和抗CD4抗体(p<0.001)之间的相关性具有统计学意义。然而,中和活性与抗HLA或抗CD4抗体之间均无统计学显著相关性。因此可以说,在一些个体中,未发生血清转化的HIV-1暴露与HIV中和抗体(并非针对病毒抗原)和/或抗细胞自身抗体相关,这些抗体可能针对感染/进入过程中涉及的细胞抗原具有特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验